Vasundhara Rasayans Ltd manufacturing and exporter Antacids therapeutic category of Active Pharm IngredientsBusiness Overview: Company offers wide range antacid therapeutic category of API andis also having an API intermediate plant to handle organic product
Vasundhara Rasayans has announced its financial results for the quarter ended June 30, 2025. The company reported a Total Income from Operations of 8.25 Cr for the period. Net Profit for the quarter stood at 0.57 Cr, leading to a Basic Earnings Per Share (EPS) of 1.80. These unaudited financial...
Vasundhara Rasayans Ltd. has confirmed its compliance regarding the handling of dematerialized shares for the quarter ended June 30, 2025. The company's Registrar and Share Transfer Agent has certified that all securities received for dematerialization were efficiently processed, accepted or rejected, and subsequently listed. This includes proper cancellation of physical...
Vasundhara Rasayans Ltd. has announced a board meeting to consider the financial results for the quarter and half-year. The company reported total income of ₹858.80 lakh for the quarter, down from ₹1,188.31 lakh in the previous quarter. Profit before tax stood at ₹65.88 lakh. Earnings per share were ₹3.87 (basic)...
Vasundhara Rasayans Ltd. has submitted a certificate confirming compliance with the Securities and Exchange Board of India (SEBI) regulations for the quarter ending March 31, 2025. This includes the confirmation of securities received for dematerialization and their subsequent acceptance by the Depositories. The securities have been properly accounted for, ensuring...
